All Health articles – Page 16
-
Business
How Covid-19 is changing drug manufacturing
Catalent is adapting, focusing on employee safety and supply chain security
-
Business
This little Crispr went to market
Gene editing technology heading towards commercial reality in pharmaceuticals, food and organ transplant
-
Opinion
Alice Ball’s treatment for leprosy
Nina Notman tells the overlooked story of historic African-American chemist Alice Ball who developed the first partially-effective treatment for leprosy
-
Podcast
Chlorine dioxide
Katrina Krämer investigates how industrial-strength bleach became promoted as ‘miracle mineral supplement’ – a supposed ‘cure’ for autism, cancer and even Covid-19.
-
News
Efforts to combat Covid-19 in India hit by imported reagent shortages
Low testing rates and supply problems have led to a search for alternatives
-
Podcast
Oleic acid
Brian Clegg discovers the link between olive oil, dandruff and stained glass windows.
-
Research
Six-month validation behind polymer that prevents biofilm growth
Zwitterionic surface could cut infections by repelling bacteria
-
Opinion
Hopes and fears for remdesivir
Available resources for testing coronavirus treatments need to be used wisely
-
Opinion
Does the drug work, or not?
Coronavirus trials reveal the murky reality of disentangling compounds’ effects on human biology
-
Business
Micropore Technologies’ model membranes make exact emulsions
Solving scalability issues to control particle size without high-shear mixing
-
Podcast
Interferon beta
An immune-modulating compound used to reduce the symptoms of multiple sclerosis and now showing potential against coronaviruses
-
Opinion
How Flint tapped in to community action
How citizen science and activism can campaign for clean and safe drinking water
-
Opinion
Inside Flint’s water crisis
Evidence of lead contamination was dismissed as resulting from a laboratory refurbishment
-
News
Explainer: how do disinfectants tackle Covid-19?
What we know about the biocides that attack the virus, and how you should use them
-
Business
PostEra points its synthesis algorithm at coronavirus
Mapping out drug discovery routes with artificial intelligence
-
Podcast
Remdesivir
Will new clinical trials for Covid-19 give remdesivir a second chance? Ben Valsler introduces the broad-spectrum antiviral that didn’t quite make it as the Ebola drug it was originally planned to be